ME Newswire / Business Wire
RESEARCH TRIANGLE PARK, N.C. - Saturday, November 23rd 2013
Quintiles
has received Scrip Awards’ Best Contract Research Organization honors
for the second year running, and Best Technological Development in
Clinical Trials for Quintiles Infosario Safety System for the first
time. The Scrip Awards acknowledge excellence in the biopharmaceutical
industry, based on judging by an independent panel of 15 life sciences
experts. The 9th annual awards ceremony, held in London, UK, was
attended by more than 400 industry leaders from around the world.
“Scrip’s
Best Contract Research Organization Award is designed to acknowledge
the critical role that CROs play in drug development and is always a
very fiercely fought category. Quintiles impressed our judges to claim
the trophy for the second year running with its commitment to
innovation, particularly with Infosario Safety System. It remains the
CRO to beat,” said Mike Ward, chief content officer for Datamonitor
Healthcare and Scrip Intelligence, the sponsor of the Scrip Awards.
“Scrip’s Best Technological Development in Clinical Trials Award
recognizes the fundamental importance of using the most sophisticated
platforms to leverage data captured during clinical studies. With
Infosario Safety System, Quintiles was one of 13 other entries and the
judges recognized the company’s cross-industry thinking in designing a
product that the whole industry could use, as well as its cost savings
and the step forward in patient safety that it delivers,” continued
Ward.
Commenting on the Best CRO Award, Quintiles’ Paula Brown
Stafford, president, Clinical Development, said: “It is an honor to be
recognized once again for our sustained leadership in the sector. I’d
like to dedicate this prestigious award to Quintiles’ employees
worldwide – the true foundation of our business.”
The Best
Technological Development in Clinical Trials Award recognized Quintiles
Infosario Safety System. Richard Thomas, chief information officer,
Quintiles, commented: “We’re delighted to receive this recognition for
Quintiles Infosario Safety System – the result of our vision to provide a
common drug safety platform for the industry. Adding best practices and
Quintiles’ deep development expertise makes this platform truly
transformational.”
About Quintiles
Quintiles (NYSE: Q) is
the world’s largest provider of biopharmaceutical development and
commercial outsourcing services with a network of more than 28,000
employees conducting business in approximately 100 countries. We have
helped develop or commercialize all of the top-50 best-selling drugs on
the market. Quintiles applies the breadth and depth of our service
offerings along with extensive therapeutic, scientific and analytics
expertise to help our customers navigate an increasingly complex
healthcare environment as they seek to improve efficiency and
effectiveness in the delivery of better healthcare outcomes. To learn
more about Quintiles, please visit www.quintiles.com.
Click here to subscribe to Mobile Alerts for Quintiles.
Contacts
Quintiles
Charlotte Taylor, + 44 118 450 8386
Media Relations
charlotte.taylor@quintiles.com
Karl Deonanan, +1-919-998-2789
Investor Relations
InvestorRelations@quintiles.com
Permalink: http://me-newswire.net/news/9274/en
No comments:
Post a Comment